Placebo News and Research

RSS
Acupuncture just as effective without needle penetration

Acupuncture just as effective without needle penetration

No benefit from nifedipine widely used to prevent premature births

No benefit from nifedipine widely used to prevent premature births

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

Selzentry (maraviroc) becomes fully approved HIV antiretrovial

CardioVascular BioTherapeutics doses first patient in trial for severe coronary heart disease

CardioVascular BioTherapeutics doses first patient in trial for severe coronary heart disease

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

Ustekinumab receives positive opinion in Europe for treatment of plaque psoriasis

FDA accepts Labopharm's NDA for formulation of trazodone

FDA accepts Labopharm's NDA for formulation of trazodone

IGF-1 not beneficial for amyotrophic lateral sclerosis

IGF-1 not beneficial for amyotrophic lateral sclerosis

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

Valdoxan - a melatonergic antidepressant - receives positive European opinion for major depressive disorder

Nplate receives positive opinion for marketing authorisation in Europe

Nplate receives positive opinion for marketing authorisation in Europe

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

Long-term use of a macrolide antibiotic reduce COPD exacerbations, raise questions

FDA approves tapentadol immediate-release tablets for pain in adults

FDA approves tapentadol immediate-release tablets for pain in adults

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

FDA accepts filing and grants priority review for DX-88 for hereditary angioedema

Gefitinib just as effective as chemotherapy for lung cancer

Gefitinib just as effective as chemotherapy for lung cancer

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

FDA approves Banzel (rufinamide) for Lennox-Gastaut syndrome

XTL Biopharmaceuticals announces results from Bicifadine in diabetic neuropathic pain trial

XTL Biopharmaceuticals announces results from Bicifadine in diabetic neuropathic pain trial

Metabolex announces positive results from phase 2 trial of MBX-8025

Metabolex announces positive results from phase 2 trial of MBX-8025

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Amgen, Takeda and Millennium update on phase 3 trial of Motesanib in non-small cell lung cancer

Ginkgo biloba does nothing for dementia, Alzheimer's

Ginkgo biloba does nothing for dementia, Alzheimer's

Accera to launch Axona, medical food product for Alzheimer's in 2009

Accera to launch Axona, medical food product for Alzheimer's in 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.